அலுவலகம் ஆஃப் தொற்று நோய்கள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from அலுவலகம் ஆஃப் தொற்று நோய்கள். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In அலுவலகம் ஆஃப் தொற்று நோய்கள் Today - Breaking & Trending Today

Good News Now, and Maybe Later, for HIV Patients


Healthy Living
Jan 28, 2021 08:07 PM By Sean Marsala
An HIV infected T-cell. NIAID / Flickr
Once considered an imminent death sentence, HIV has become a more treatable, albeit chronic, disease in recent years. Patients with well-managed HIV can now live long and largely normal lives, if they have stamina. The effort required to keep the virus contained with a daily cocktail of pills has been significant. But that might change: Two new treatments hold great promise in the fight against HIV: one that replaces those pills, and another that may eventually lead to disease prevention.
 Testing first with pills
The FDA recently approved Cabenuva, the first extended-release injectable HIV treatment. Developed by ViiV Healthcare, Cabenuva is administered once a month and is intended as a long-acting replacement to the current regimens of patients whose HIV is already well-controlled. ....

Anthonys Fauci , John Farley , Office Of Infectious Diseases , National Institute Of Allergy , Viiv Healthcare , Infectious Diseases , Drug Evaluation , Antibody Mediated Prevention , National Institute , Hiv Prevention , Hiv Treatment , Antibody Treatment , ஜான் ஃபார்லீ , அலுவலகம் ஆஃப் தொற்று நோய்கள் , தேசிய நிறுவனம் ஆஃப் ஒவ்வாமை , தொற்று நோய்கள் , மருந்து மதிப்பீடு , ஆன்டிபாடி மத்தியஸ்தம் ப்ரெவெந்ஶந் , தேசிய நிறுவனம் , எசைவீ ப்ரெவெந்ஶந் , எசைவீ சிகிச்சை , ஆன்டிபாடி சிகிச்சை ,

FDA OKs First Injectable Complete Drug Regimen for HIV

FDA OKs First Injectable Complete Drug Regimen for HIV
medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.

John Farley , Office Of Infectious Diseases , Drug Administration , Infectious Diseases , Drug Evaluation , ஜான் ஃபார்லீ , அலுவலகம் ஆஃப் தொற்று நோய்கள் , தொற்று நோய்கள் , மருந்து மதிப்பீடு ,

FDA Approves First Once-a-Month Injectable Drug Regimen for People Living with HIV


FDA Approves First Once-a-Month Injectable Drug Regimen for People Living with HIV
The FDA this week approved the use of once-a-month injectable Cabenuva for people living with HIV.
The FDA reports: “The U.S. Food and Drug Administration today approved Cabenuva (cabotegravir and rilpivirine, injectable formulation) as a complete regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults to replace a current antiretroviral regimen in those who are virologically suppressed on a stable antiretroviral regimen with no history of treatment failure and with no known or suspected resistance to either cabotegravir or rilpivirine. This is the first FDA-approved injectable, complete regimen for HIV-infected adults that is administered once a month.” ....

John Farley , Office Of Infectious Diseases , Drug Administration , Infectious Diseases , Drug Evaluation , ஜான் ஃபார்லீ , அலுவலகம் ஆஃப் தொற்று நோய்கள் , தொற்று நோய்கள் , மருந்து மதிப்பீடு ,

ViiV Healthcare obtains FDA OK for HIV drug regimen

ViiV Healthcare obtains FDA OK for HIV drug regimen
drugstorenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from drugstorenews.com Daily Mail and Mail on Sunday newspapers.

John Farley , Office Of Infectious Diseases , Drug Administration , Viiv Healthcare , Infectious Diseases , Drug Evaluation , ஜான் ஃபார்லீ , அலுவலகம் ஆஃப் தொற்று நோய்கள் , தொற்று நோய்கள் , மருந்து மதிப்பீடு ,